Intendis is a specialized pharmaceutical company focused on the Dermatologicals category. Headquartered in Berlin, Germany the company was founded in 2005 as a subsidiary of Schering AG. Intendis has a successful track record of providing prescription drug products for the treatment of severe skin diseases and was a pioneer in the development of locally applicable corticosteroid treatments.